Research and Markets: Global Cell Surface Testing Market 2016 - Supplier Shares, Competitive Intelligence, Emerging Opportunities

Research and Markets (http://www.researchandmarkets.com/research/2t78x2/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the Global Cell Surface Testing Market: Supplier Shares, Competitive Intelligence, Emerging Opportunities" report to their offering.

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.

This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment.

The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Competitive Assessments

• Abbott
• Agilent Technologies
• Beckman Coulter/Danaher
• Becton Dickinson
• Bio-Rad
• CellaVision
• Horiba
• Iris Diagnostics/Danaher
• Nihon Kohden
• Ortho-Clinical Diagnostics
• Roche
• Siemens
• Sysmex
  

For more information visit http://www.researchandmarkets.com/research/2t78x2/2016_future

View source version on businesswire.com: http://www.businesswire.com/news/home/20151125005228/en/